Avoiding 510(k) Submission Gaps: Practical Human Factors Engineering Strategies to Reduce Rework, FDA Questions, and Project Delays

April 28, 2026 | 1:00 pm ET Overview Early human factors engineering (HFE) decisions directly influence the strength, defensibility, and efficiency of Food and Drug Administration (FDA) 510(k) sub...

Preventing Cisplatin-Induced Ototoxicity in Pediatrics: What You Need to Know to Improve Patient Outcomes

Overview  Cisplatin is a commonly used chemotherapeutic agent for the treatment of certain childhood cancers, including germ cell tumors, hepatoblastoma, medulloblastoma, neuroblastoma, and osteosa...